Cited by 350Diabetes Management and ResearchPain Mechanisms and TreatmentsDiabetic Foot Ulcer Assessment and Management

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion

Open access

Martin, Catherine L., Albers, James, Herman, William H., Cleary, Patricia, Waberski, Barbara, Greene, Douglas A., Stevens, Martin J., Feldman, Eva L.·2006·Diabetes Care

DOI 10.2337/diacare.29.02.06.dc05-1549PMC PMC2622720

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE—To evaluate the impact of prior intensive diabetes therapy on neuropathy among former Diabetes Control and Complications Trial (DCCT) participants. RESEARCH DESIGN AND METHODS—At the conclusion of the DCCT, subjects in the intensive group were encouraged to maintain intensive therapy, and subjects in the conventional group were encouraged to begin intensive therapy. Thereafter, we annually assessed neuropathy as part of the Epidemiology of Diabetes Intervention and Complications (EDIC) study. Neuropathy was defined using the Michigan Neuropathy Screening Instrument (MNSI). We recorded potential adverse consequences of neuropathy. RESULTS—At the first EDIC examination, 1,257 subjects participated in the neuropathy assessment. Consistent with DCCT results, the former intensive group showed a lower prevalence of neuropathy than the conventional group based on positive questionnaire (1.8 vs. 4.7%; P = 0.003) or examination (17.8 vs. 28.0%; P < 0.0001) results. Despite similar levels of glycemic control, symptoms and signs of neuropathy remained less prevalent among the former intensive group compared with the conventional group. At the beginning of the EDIC study, prior intensive therapy reduced the odds of having symptoms and signs of neuropathy using MNSI criteria by 64% (P = 0.0044) and 45% (P < 0.0001), respectively, with similar odds reductions observed for both neuropathic symptoms (51%, P < 0.0001) and neuropathic signs (43%, P < 0.0001) across 8 years of EDIC follow-up. CONCLUSIONS—The benefits of 6.5 years of intensive therapy on neuropathy status extended for at least 8 years beyond the end of the DCCT, similar to the findings described for diabetic retinopathy and nephropathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/diacare.29.02.06.dc05-1549

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,291
Self-citation
Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2003) · JAMA · doi:10.1001/jama.290.16.2159 · Cited by 1,009
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
(1999) · Diabetes Care · doi:10.2337/diacare.22.1.99 · Cited by 662
The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy
The Diabetes Control and Complications Trial Research Group. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00001 · Cited by 602
Implementation of Treatment Protocols in the Diabetes Control and Complications Trial
Diabetes Control and Complications Trial Research Group (1995) · Diabetes Care · doi:10.2337/diacare.18.3.361 · Cited by 285

Show all 15 references

Sorted by citations

Items 101–200 of 350

Glucose intolerance, metabolic syndrome, and neuropathy
Cortez, M. M., Singleton, J. R., & Smith, A. G. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00009-6 · Cited by 53
Early Electrophysiological Abnormalities and Clinical Neuropathy
Hyllienmark, L., Alstrand, N., Jönsson, B., Ludvigsson, J., Cooray, G., & Wahlberg-Topp, J. (2013) · Diabetes Care · doi:10.2337/dc12-2226 · Cited by 52
Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study
Santos, T. R. M., de Melo, J. V., Leite, N. C., Salles, G. F., & Cardoso, C. R. L. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.010 · Cited by 51
Recent Advances in Biomarkers and Regenerative Medicine for Diabetic Neuropathy
Fujita, Y., Murakami, T., & Nakamura, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052301 · Cited by 49
Pharmacist Scope of Practice, Standards of Practice, and Standards of Professional Performance for Diabetes Educators
Shane‐McWhorter, L., Armor, B. L., Johnson, J. T., Letassy, N. A., Reichert, S. L., Sisson, E. M., Hanson, J. B. S., Triplett, C., & Vivian, E. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709349590 · Cited by 49
Focal and multifocal diabetic neuropathies
Saïd, G. (2007) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2007000700037 · Cited by 47
Diabetic neuropathy
Charnogursky, G. A., Lee, H. X., & Lopez, N. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00051-6 · Cited by 50
Therapeutic Strategies for Diabetic Neuropathy
Habib, A. A., & Brannagan, T. H. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0093-7 · Cited by 46
The relationship between obstructive sleep apnea and intra-epidermal nerve fiber density, PARP activation and foot ulceration in patients with type 2 diabetes
Altaf, Q., Ali, A., Piya, M. K., Raymond, N. T., & Tahrani, A. A. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.025 · Cited by 47
Hearing Loss in Type 2 Diabetes in Association with Diabetic Neuropathy
Ren, H., Wang, Z., Mao, Z., Zhang, P., Wang, C., Liu, A., & Yuan, G. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.02.001 · Cited by 45
Effects of Prior Intensive Versus Conventional Therapy and History of Glycemia on Cardiac Function in Type 1 Diabetes in the DCCT/EDIC
GENUTH, S. M., Backlund, J. C., Bayless, M., Bluemke, D. A., Cleary, P. A., Crandall, J. P., Lachin, J. M., Lima, J. A. C., Miao, C., & Turkbey, E. B. (2013) · Diabetes · doi:10.2337/db12-0546 · Cited by 44
Self-citation
Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy
Ko, S. ‐., Kwon, H., Yu, J., Baik, S. H., Park, I. B., Lee, J., Ko, K. S., Noh, J. H., Kim, D. ‐., Kim, C. H., et al. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03054.x · Cited by 43
Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic
Zhou, J., Zhang, Z., & Qian, G. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.55 · Cited by 42
Prevalence of Diabetic Neuropathy in Patients Undergoing Foot and Ankle Surgery
Suder, N. C., & Wukich, D. K. (2012) · Foot & Ankle Specialist · doi:10.1177/1938640011434502 · Cited by 40
Autonomic nervous system function in type 2 diabetes using conventional clinical autonomic tests, heart rate and blood pressure variability measures
Sucharita, S., Bantwal, G., Idiculla, J. M., Ayyar, V. S., & Vaz, M. A. P. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.83406 · Cited by 40
Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up
Jann, S., Bramerio, M. A., Facchetti, D., & Sterzi, R. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.149013 · Cited by 40
Importance of controlling diabetes early--the concept of metabolic memory, legacy effect and the case for early insulinisation.
Unnikrishnan, I. R., Anjana, R. M., & Mohan, V. (2011) · PubMed · Cited by 38
Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice
Comelli, F., Bettoni, I., Colombo, A., Fumagalli, P., Giagnoni, G., & Costa, B. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.061 · Cited by 39
Plantar pressure distribution in diverse stages of diabetic neuropathy
Abri, H., Aalaa, M., Sanjari, M., Amini, M. R., Mohajeri‐Tehrani, M. R., & Larijani, B. A. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00387-1 · Cited by 39
Randomized Controlled Trial of Physical Exercise in Diabetic Veterans With Length-Dependent Distal Symmetric Polyneuropathy
Stubbs, E. B., Fisher, M. A., Miller, C. M., Jelinek, C. S., Butler, J., McBurney, C., & Collins, E. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00051 · Cited by 41
Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis
Cengiz, E., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., KLINGENSMITH, G. J., Tamborlane, W. V., Lee, J. M., & Haller, M. J. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12068 · Cited by 37
Autophagy: The missing link in diabetic neuropathy?
Yerra, V. G., Gundu, C., Bachewal, P., & Kumar, A. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.11.004 · Cited by 37
Infiltration of Blood-Derived Macrophages Contributes to the Development of Diabetic Neuropathy
Sun, J., Tang, L., Zhao, X.-P., Xu, J., Xiao, Y., & Li, H. (2019) · Journal of Immunology Research · doi:10.1155/2019/7597382 · Cited by 38
Intraperitoneal Insulin Infusion Versus Islet Transplantation: Comparative Study in Patients with Type 1 Diabetes
Vantyghem, M., Marcelli-Tourvieille, S., Fermon, C., Duhamel, A., Raverdy, V., Arnalsteen, L., Kerr-Conte, J. A., Noël, C., Fontaine, P., & Pattou, F. N. (2009) · Transplantation · doi:10.1097/tp.0b013e31818bbdab · Cited by 40
Glucotoxic Mechanisms and Related Therapeutic Approaches
Yagihashi, S. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.03.006 · Cited by 35
Mesenchymal Stem Cells as a Prospective Therapy for the Diabetic Foot
Wu, Q., Chen, B., & Liang, Z. (2016) · Stem Cells International · doi:10.1155/2016/4612167 · Cited by 38
Recognition and management of psychosocial issues in diabetic neuropathy
Vileikytė, L., & Gonzalez, J. S. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00013-8 · Cited by 36
Exploring a New Therapy for Diabetic Polyneuropathy – The Application of Stem Cell Transplantation
Mizukami, H., & Yagihashi, S. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00045 · Cited by 34
Trends in Postoperative Infection Rates and Their Relationship to Glycosylated Hemoglobin Levels in Diabetic Patients Undergoing Foot and Ankle Surgery
Jupiter, D. C., Humphers, J. M., & Shibuya, N. (2013) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2013.10.003 · Cited by 33
Vascular memory: can we broaden the concept of the metabolic memory?
Jermendy, G. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-44 · Cited by 36
Assessment of Triglyceride–Glucose Index and Ratio in Patients with Type 2 Diabetes and Their Relation to Microvascular Complications
Kassab, H. S., Osman, N. A., & Elrahmany, S. M. (2023) · Endocrine Research · doi:10.1080/07435800.2023.2245909 · Cited by 31
Diabetic neuropathy in children and youth: New and emerging risk factors
Akıncı, G., Savelieff, M. G., Gallagher, G., Callaghan, B. C., & Feldman, E. L. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13153 · Cited by 30
Self-citation
Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
Ponirakis, G., Abdul‐Ghani, M. A., Jayyousi, A., Zirie, M. A., Qazi, M., Almuhannadi, H., Petropoulos, I. N., Khan, A., Gad, H., Migahid, O., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13544 · Cited by 30
Standardized Aqueous Tribulus terristris (Nerunjil) Extract Attenuates Hyperalgesia in Experimentally Induced Diabetic Neuropathic Pain Model: Role of Oxidative Stress and Inflammatory Mediators
Ravichandran, R., Balaji, S. P., Balaji, B., Ramesh, R. V., & Ramanathan, M. (2012) · Phytotherapy Research · doi:10.1002/ptr.4915 · Cited by 30
Development and evaluation by a cluster randomised trial of a psychosocial intervention in children and teenagers experiencing diabetes: the DEPICTED study
Gregory, J. W., Robling, M. R., Bennert, K., Channon, S., Cohen, D. R., Crowne, E. C., Hambly, H., Hawthorne, K., Hood, K., Longo, M., et al. (2011) · Health Technology Assessment · doi:10.3310/hta15290 · Cited by 30
Pharmacologic management of diabetic peripheral neuropathic pain
Iyer, S. N., & Tanenberg, R. J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.811490 · Cited by 30
Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences
Tahrani, A. A., Altaf, Q., Piya, M. K., & Barnett, A. H. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1273789 · Cited by 29
Stem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions
Akter, S., Choubey, M., Mohib, M. M., Arbee, S., Sagor, M. A. T., & Mohiuddin, M. S. (2023) · Brain Sciences · doi:10.3390/brainsci13020255 · Cited by 29
Comparison of Digital and Film Grading of Diabetic Retinopathy Severity in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
Hubbard, L. D. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.136 · Cited by 29
Glycemic control paradox: Poor glycemic control associated with higher one-year and eight-year risks of all-cause hospitalization but lower one-year risk of hypoglycemia in patients with type 2 diabetes
Li, T., Kardia, S. L. R., Li, C.-I., Chen, C., Liu, C.-S., Yang, S.-Y., Muo, C.-S., Peyser, P. A., & Lin, C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.05.004 · Cited by 26
Peripheral neuropathy in the elderly
SUZUKI, M. T. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00046-1 · Cited by 26
Methods and initial findings from the Durham Diabetes Coalition: Integrating geospatial health technology and community interventions to reduce death and disability
Spratt, S. E., Batch, B. C., Davis, L., Dunham, A. A., Easterling, M., Feinglos, M. N., Granger, B. B., Harris, G., Lyn, M., Maxson, P. J., et al. (2015) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.10.006 · Cited by 26
Sintomas depressivos e qualidade de vida em pacientes diabéticos tipo 2 com polineuropatia distal diabética
Moreira, R. O., Amâncio, A. P. R. L., Brum, H. R., Vasconcelos, D. L., & Nascimento, G. F. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000900007 · Cited by 26
Patterns of Nerve Conduction Abnormalities in Patients with Type 2 Diabetes Mellitus According to the Clinical Phenotype Determined by the Current Perception Threshold
Park, J. H., & Won, J. C. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0068 · Cited by 26
NEUROPATHIC PROBLEMS OF THE LOWER LIMBS IN DIABETIC PATIENTS
Tanenberg, R. J., & Donofrio, P. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04145-4.50010-7 · Cited by 27
A curcumin derivative J147 ameliorates diabetic peripheral neuropathy in streptozotocin (STZ)-induced DPN rat models through negative regulation AMPK on TRPA1
Lv, J., Cao, L., Zhang, R., Bai, F., & Wei, P. (2018) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020180060000008 · Cited by 26
Neuropathy of the elderly
Bouché, P. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2019.11.007 · Cited by 26
Diabetes Education: the Experiences of Young Adults with Type 1 Diabetes
Wiley, J., Westbrook, M. T., Long, J. C., Greenfield, J. R., Day, R. O., & Braithwaite, J. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0056-0 · Cited by 26
Glucose control in diabetes: which target level to aim for?
Laakso, M., & Cederberg, H. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02528.x · Cited by 25
Diabetic Peripheral Neuropathic Pain
King, S. A. (2006) · Cited by 24
State of the art papers Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy
Kasznicki, J. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.42588 · Cited by 27
Novel therapeutics and targets for the treatment of diabetes
Aicher, T. D., Boyd, S. A., McVean, M., & Celeste, A. J. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.1 · Cited by 21
Urogenital Autonomic Dysfunction in Diabetes
Braffett, B. H., Wessells, H., & Sarma, A. V. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0824-5 · Cited by 23
Impaired Mitochondrial Respiration in Large Cerebral Arteries of Rats with Type 2 Diabetes
Merdžo, I., Rutkai, I., Sure, V. N. L. R., McNulty, C. A., Katakam, P. V. G., & Busija, D. W. (2017) · Journal of Vascular Research · doi:10.1159/000454812 · Cited by 23
Diabetic Polyneuropathy – Advances in Diagnosis and Intervention Strategies
Tesfaye, S. H., & SLOAN, G. P. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.1.15 · Cited by 23
Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries
Rahimian, S., Najafi, H., Webber, C. A., & Jalali, H. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04157-1 · Cited by 28
Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes
Gibbons, C. H., & GOEBEL-FABBRI, A. E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0880-5 · Cited by 22
Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: Engagement of antioxidant mechanism
Hu, P. L., Mei, Q., Ma, L., Cui, W., Zhou, W., Zhou, D., Zhao, Q. C., Xu, D., Zhao, X., Lu, Q., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.024 · Cited by 21
Screening and Treatment by the Primary Care Provider of Common Diabetes Complications
Gilbert, M. P. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.09.002 · Cited by 22
Neurologic Complications of Diabetes
Charnogursky, G. A., Emanuele, N., & Emanuele, M. A. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0457-5 · Cited by 20
Murine model and mechanisms of treatment-induced painful diabetic neuropathy
Nicodemus, J. M., Enriquez, C., Marquez, A. M., Anaya, C. J., & Jolivalt, C. G. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.036 · Cited by 22
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 19
Performance Analysis of Conventional Machine Learning Algorithms for Diabetic Sensorimotor Polyneuropathy Severity Classification Using Nerve Conduction Studies
Haque, F., Reaz, M. B. I., Chowdhury, M. E. H., Serkan Kiranyaz, B., Ali, S. H. M., Alhatou, M. I., Habib, R., Bakar, A. A. A., Arsad, N., & Srivastava, G. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/9690940 · Cited by 19
A Machine Learning-Based Severity Prediction Tool for the Michigan Neuropathy Screening Instrument
Haque, F., Reaz, M. B. I., Chowdhury, M. E. H., Shapiai, M. I., Malik, R. A., Alhatou, M. I., Kobashi, S., Ara, I., Ali, S. H. M., Bakar, A. A. A., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13020264 · Cited by 20
Diabetic Neuropathy: Medical and Surgical Approaches
Dellon, A. L. (2007) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2007.03.003 · Cited by 19
Diabetische Neuropathie und diabetischer Fuß (Update 2019)
Lechleitner, M., Abrahamian, H., Francesconi, C., Kofler, M., Sturm, W., & Köhler, G. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1487-4 · Cited by 18
Precision of Michigan Neuropathy Screening Instrument (MNSI) Tool for the Diagnosis of Diabetic Peripheral Neuropathy Among People with Type 2 Diabetes—A Study from South India
Viswanathan, V., Khan, B. A., Nachimuthu, S., & Kumpatla, S. (2023) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346231163209 · Cited by 18
Incidence, prevalence, and trend analysis of the use of insulin delivery systems in the United States (2005 to 2011)
Perez‐Nieves, M., Jiang, D., & Eby, E. L. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1020366 · Cited by 18
Recent clinical advances in diabetic polyneuropathy
Horowitz, S. H. (2006) · Current Opinion in Anaesthesiology · doi:10.1097/01.aco.0000245287.37905.c5 · Cited by 17
Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.
Davidson, M. B., Duran, P. A., & Lee, M. L. (2014) · PubMed · Cited by 18
Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?
McGill, J. B., Ahn, D. T., Edelman, S. V., Kilpatrick, C. R., & Cavaiola, T. S. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0370-1 · Cited by 18
Bilirubin is inversely related to diabetic peripheral neuropathy assessed by sural nerve conduction study
Abe, K., Maeda, Y., Matsuzaki, C., Yokomizo, H., Inoue, T., Sonoda, N., Ogawa, Y., & Inoguchi, T. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13568 · Cited by 16
Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes
Paisey, R., Darby, T., George, A. M., Waterson, M., Hewson, P., Paisey, C., & Thomson, M. P. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000163 · Cited by 16
Therapeutic management of diabetic kidney disease
Koya, D., Araki, S., & Haneda, M. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00112.x · Cited by 16
Development and validation of a cost–utility model for Type 1 diabetes mellitus
Wolowacz, S. E., Pearson, I. V., Shannon, P. A., Chubb, B., Gundgaard, J., Davies, M. J., & Briggs, A. H. (2014) · Diabetic Medicine · doi:10.1111/dme.12663 · Cited by 16
Evolution of the study coordinator role: The 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)
Larkin, M. E., Lorenzi, G. M., Bayless, M., Cleary, P. A., Barnie, A., Golden, E., HITT, S. M., & GENUTH, S. M. (2012) · Clinical Trials · doi:10.1177/1740774512449532 · Cited by 15
Self-citation
Neuropathy in the DCCT/EDIC—What Was Done Then and What We Would Do Better Now
Pop‐Busui, R., & Martin, C. L. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.020 · Cited by 15
Self-citation
Therapy for diabetic neuropathy
Calabek, B., Callaghan, B. C., & Feldman, E. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00022-9 · Cited by 15
Self-citation
Diabetes - Damages and Treatments
Rigobelo, E. C. (2011) · InTech eBooks · doi:10.5772/1823 · Cited by 15
Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN)
Sharma, S., & Rayman, G. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1165505 · Cited by 18
A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations
Haque, F., Reaz, M. B. I., Chowdhury, M. E. H., Ali, S. H. M., Bakar, A. A. A., Rahman, T., Kobashi, S., Dhawale, C. A., & Bhuiyan, M. A. S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104954 · Cited by 14
A Current Overview of Diabetic Neuropathy – Mechanisms, Symptoms, Diagnosis, and Treatment
Kawano, T. (2014) · InTech eBooks · doi:10.5772/58308 · Cited by 15
Puerarin prevents high glucose-induced apoptosis of Schwann cells by inhibiting oxidative stress.
Wu, Y., Xue, B., Li, X., & Liu, H. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.33.003 · Cited by 14
Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM
Kesavadev, J., SADIKOT, S. M., WANGNOO, S. K., Kannampilly, J., Saboo, B., Aravind, S. R., Kalra, S., Makkar, B. M., Maji, D., Saikia, M., et al. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.030 · Cited by 14
The Question Is, My Dear Watson, Why Did the Dog Not Bark?
Vinik, A. I. (2011) · Diabetes Care · doi:10.2337/dc11-0146 · Cited by 13
Efficiency of Michigan Neuropathy Screening Instrument and Nerve Conduction Studies for Diagnosis of Diabetic Distal Symmetric Polyneuropathy
Muntean, C., Cătălin, B., Tudorică, V., & Moța, M. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0007 · Cited by 13
Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine
Bellows, B. K., Nelson, R. E., Oderda, G. M., & LaFleur, J. (2015) · Pain · doi:10.1097/j.pain.0000000000000350 · Cited by 13
Cardiovascular Risk Factors Predicting the Development of Distal Symmetrical Polyneuropathy in People with Type 1 Diabetes
Sibal, L., LAW, H. N., Gebbie, J., & Home, P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.036 · Cited by 13
Treatment options for the management of diabetic painful neuropathy: best current evidence
McKeage, K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32828da14e · Cited by 12
Exercise training improves the soleus muscle morphology in experimental diabetic nerve regeneration
Malysz, T., Ilha, J., do Nascimento, P. S., Faccioni‐Heuser, M. C., Angelis, K. D., Schaan, B. D., & Achaval, M. (2011) · Muscle & Nerve · doi:10.1002/mus.22133 · Cited by 13
Association of aldose reductase gene polymorphism (C-106T) in susceptibility of diabetic peripheral neuropathy among north Indian population
Gupta, B., & Singh, S. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.011 · Cited by 11
Standard and Emerging Treatment Options for Diabetic Neuropathy
Tentolouris, N., Αλεξιάδου, Κ., Makrilakis, K., Liatis, S., Jude, E. B., & Boulton, A. J. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660682 · Cited by 11
Current glycaemic control has no impact on the advancement of diabetic neuropathy.
Dziemidok, P., Szczęśniak, G., Kostrzewa-Zabłocka, E., Paprzycki, P., & Korzon-Burakowska, A. (2012) · PubMed · Cited by 11
Insulin-Ameliorated Peripheral Motor Neuropathy in Spontaneously Diabetic WBN/Kob Rats
Ozaki, K., Yamano, S., Matsuura, T., & Narama, I. (2013) · Journal of Veterinary Medical Science · doi:10.1292/jvms.13-0184 · Cited by 11
Metabolic memory and diabetic retinopathy: Legacy of glycemia and possible steps into future
Sheemar, A., Bellala, K., Sharma, S. V., Sharma, S., Kaur, I., Rani, P. K., Sivaprasad, S., Narayan, K. M. V., Das, T., & Takkar, B. (2024) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2563_23 · Cited by 11
A modelling study of the budget impact of improved glycaemic control in adults with Type 1 diabetes in the UK
Choudhary, P., de Portu, S., Delbaere, A., Lyon, J., & Pickup, J. C. (2019) · Diabetic Medicine · doi:10.1111/dme.13924 · Cited by 10
The time to develop treatments for diabetic neuropathy
Rendell, M. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1868433 · Cited by 10
Effects of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline on a diabetic neuropathic pain model
Tokhi, A., Ahmed, Z. S., Arif, M., Rehman, N. U., Sheibani, V., Sewell, R. D. E., & Rauf, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1128496 · Cited by 11
Review: Metabolic memory in type 1 diabetes
Wright, A. D. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409351645 · Cited by 10
Understanding Biochemical and Molecular Mechanism of Complications of Glycation and Its Management by Herbal Medicine
Qais, F. A., Khan, M. S., Althubiani, A. S., Alghamdi, S., & Ahmad, I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814619-4.00013-6 · Cited by 10

Authors: Martin, C. L., Albers, J., Herman, W. H., Cleary, P., Waberski, B., Greene, D. A., Stevens, M. J., & Feldman, E. L.
Affiliations: Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group
ORCID: Martin, Catherine L.
Stevens, Martin J.
Feldman, Eva L.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2006-02-01
Volume: 29
Issue: 2
Pages: 340-344
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.29.02.06.dc05-1549
PMC: PMC2622720
OpenAlex: W2010740931
Cited by: 350
References: 15
Citations by year: 2026: 4 · 2025: 2 · 2024: 6 · 2023: 14 · 2022: 7 · 2021: 8 · 2020: 14 · 2019: 11 · 2018: 16 · 2017: 16 · 2016: 17 · 2015: 19 · 2014: 30 · 2013: 26 · 2012: 22
FWCI: 20.92
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Eli Lilly and Company
National Institutes of Health (n01dk062204-003)
National Institute of Diabetes and Digestive and Kidney Diseases (N01 DK062204)
National Center for Research Resources
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
Keywords: diabetic neuropathy, intensive diabetes therapy, Diabetes Control and Complications Trial, Michigan Neuropathy Screening Instrument, glycemic control, long-term follow-up, type 1 diabetes
MeSH terms: Diabetes Mellitus, Type 1, Diabetic Neuropathies, Follow-Up Studies, Health Surveys, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks